BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moody TW, Jensen RT. Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide (Part 2): biology and clinical importance in central nervous system and inflammatory disorders. Curr Opin Endocrinol Diabetes Obes 2021;28:206-13. [PMID: 33481421 DOI: 10.1097/MED.0000000000000621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Patko E, Szabo E, Toth D, Tornoczky T, Bosnyak I, Vaczy A, Atlasz T, Reglodi D. Distribution of PACAP and PAC1 Receptor in the Human Eye. J Mol Neurosci 2022. [PMID: 35253081 DOI: 10.1007/s12031-022-01985-0] [Reference Citation Analysis]
2 Sokolov AY, Osipchuk AV, Skiba IB, Amelin AV. The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis. Neurochem J 2022;16:31-8. [DOI: 10.1134/s1819712422010123] [Reference Citation Analysis]
3 Jana B, Całka J, Witek K. Investigation of the Role of Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and Its Type 1 (PAC1) Receptor in Uterine Contractility during Endometritis in Pigs. Int J Mol Sci 2022;23:5467. [PMID: 35628275 DOI: 10.3390/ijms23105467] [Reference Citation Analysis]
4 D'Amico AG, Maugeri G, Vanella L, Pittalà V, Reglodi D, D'Agata V. Multimodal Role of PACAP in Glioblastoma. Brain Sci 2021;11:994. [PMID: 34439613 DOI: 10.3390/brainsci11080994] [Reference Citation Analysis]